Insmed Incorporated
700 US Highway 202/206
Bridgewater
New Jersey
08807
United States
Tel: (908)977-9900
Website: https://insmed.com/
Email: talentacquisition@insmed.com
About Insmed Incorporated
Insmed is a global biopharmaceutical company on a mission to transform the lives of patients living with serious and rare diseases. Our most valuable resource is our employees, and everything we do is motivated by a patients-first mentality. We are dedicated to growing our team with talented individuals from around the world who are willing to challenge the status quo, solve problems, and work collaboratively with a sense of urgency and compassion.
Guided by our core values of collaboration, accountability, passion, respect, and integrity, we aim to foster an inclusive, diverse, and flexible work environment, where our employees are recognized for leaning in and rolling up their sleeves. If you share our vision and want to work with the most dedicated people in the biopharma industry, come to Insmed to accelerate your career.
CONNECT
455 articles about Insmed Incorporated
-
Insmed Incorporated Appoints Donald J. Hayden, Jr. as Executive Chairman
5/16/2012
-
Insmed Incorporated Announces First Quarter 2012 Financial Results
5/8/2012
-
FDA Lifts Second Hold on Trials of Insmed Incorporated Lung Drug
5/7/2012
-
Insmed Incorporated to Host 2012 First Quarter Earnings Conference Call
4/24/2012
-
Insmed Incorporated Announces First Patient Dosed in Pivotal European Phase 3 Clinical Study of ARIKACEĀ® in Cystic Fibrosis Patients with Pseudomonas Lung Infections
4/16/2012
-
Insmed Incorporated Announces Fourth Quarter and Full-Year 2011 Financial Results
3/13/2012
-
Insmed Incorporated to Host Fourth Quarter and 2011 Year-End Earnings Conference Call
2/28/2012
-
Insmed Incorporated Provides Update on Clinical Program for ARIKACE(R)
2/10/2012
-
FDA Lifts Hold on Insmed Incorporated's Lung Disease Drug
1/24/2012
-
Insmed Incorporated to Present at Lazard Capital Markets 8th Annual Healthcare Conference
11/14/2011
-
Insmed Incorporated Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2011
11/8/2011
-
Insmed Incorporated to Host 2011 Third Quarter Earnings Conference Call
10/25/2011
-
Insmed Incorporated Provides Regulatory Update on ARIKACE(R) in Non-Tuberculous Mycobacteria Indication
10/14/2011
-
Insmed Incorporated Slumped on October 10, 2011 as FDA Keeps Hold on Lung Treatment Trial
10/11/2011
-
Insmed Incorporated to Present at Sixth Annual JMP Securities Healthcare Conference
9/26/2011
-
Insmed Incorporated to Present at 2011 Wedbush Securities Life Sciences Management Access Conference
8/11/2011
-
Insmed Incorporated Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011
8/8/2011
-
Insmed Incorporated Slammed as FDA Puts Clinical Hold on ARIKACE
8/3/2011
-
Insmed Incorporated to Host 2011 Second Quarter Earnings Conference Call
7/26/2011
-
Andrea Drucker Joins Insmed Incorporated as General Counsel
7/18/2011